Net income at United Therapeutics Corp. surged more than four-fold in its latest quarter as sales rose and the Silver Spring pharmaceutical firm curbed expenses.
United Therapeutics (NASDAQ: UTHR) maintained the sales growth momentum of its line-up of cardiopulmonary hypertension medicines in the fourth quarter. Total revenue increased 19 percent to $195.2 million.
To read the full, original article click on this link: United Therapeutics net income jumps to $43.2M – Washington Business Journal
{iframe}http://www.bizjournals.com/washington/news/2012/02/14/united-therapeutics-net-income-jumps.html?ed=2012-02-14&s=article_du&ana=e_du_pap{/iframe}